Hypertrophic Scars and Keloids: Advances in Treatment and Review of Established Therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypertrophic Scars and Keloids: Advances in Treatment and Review of Established Therapies

Published:2023-01-20 Issue:2 Volume:24 Page:225-245
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:Am J Clin Dermatol

Author:

Frech Fabio Stefano,Hernandez Loren,Urbonas Rebecca,Zaken Ghufran Abo,Dreyfuss Isabella,Nouri Keyvan

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40257-022-00744-6.pdf

Reference228 articles.

1. Ghazawi FM, Zargham R, Gilardino MS, Sasseville D, Jafarian F. Insights into the pathophysiology of hypertrophic scars and keloids: how do they differ? Adv Skin Wound Care. 2018;31(1):582–95.

2. Feng Y, Wu JJ, Sun ZL, Liu SY, Zou ML, Yuan ZD, et al. Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation. EBioMedicine. 2020;54: 102715.

3. Elsaie ML. Update on management of keloid and hypertrophic scars: a systemic review. J Cosmet Dermatol. 2021;20(9):2729–38.

4. Darby IA, Desmoulière A. Scar formation: cellular mechanisms. In: Téot L, Mustoe TA, Middelkoop E, Gauglitz GG, editors. Textbook on scar management: state of the art management and emerging technologies. Cham: Springer International Publishing; 2020. p. 19–26.

5. Hoffmann A, Hoing JL, Newman M, Simman R. Role of hyaluronic acid treatment in the prevention of keloid scarring. 2013.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of α7nAchR and PD-L1 in neuroimmune regulation of keloid treatment;Cellular Signalling;2024-09

2. Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway;Biomolecules and Biomedicine;2024-08-10

3. Serum deprivation protein response intervenes in the proliferation, motility, and extracellular matrix production in keloid fibroblasts by blocking the amplification of TGF-β1/SMAD signal cascade via ERK1/2;Toxicology and Applied Pharmacology;2024-08

4. Evaluating the Content and Quality of Videos Related to Hypertrophic Scarring on TikTok in China (Preprint);2024-07-26

5. Isorhamnetin inhibits hypertrophic scar formation through TGF-β1/Smad and TGF-β1/CREB3L1 signaling pathways;Heliyon;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3